Press release
Uncategorized

MedX Health Corp. announces Dr. Paul Cohen as Medical Spokesperson

MISSISSAUGA, ON — January 25, 2024 – MedX Health Corp. (“MedX” or the “Company”) (TSX VENTURE: MDX) is pleased to announce that it has appointed Dr. Paul Cohen, a board-certified dermatologist and Fellow of the Royal College of Physicians and Surgeons of Canada, as Medical Spokesperson. Dr. Cohen is also a diplomat of the American Board of Dermatology and is a member of numerous associations, including the Canadian Dermatological Association and the Toronto Dermatological Society.

Press release
Uncategorized

November 14, MedX Health Corp. Announces Closing of Non-brokered Private Placement and Amendment of Terms of Warrants Issued in April, May and July, 2020

Mississauga, ON, November 14, 2023.  MedX Health Corp. (“MedX” or the “Company”) (TSX-V: MDX) announced today that, it has submitted for Final Acceptance from the TSXV and has closed the non-brokered Private Placement which was previously announced on August 30, 2023.  The placement, to accredited investors, raised $1,020,000 by issuance of 14,571,428 units at $0.07per unit (“Unit”)

Press release
Uncategorized

May 10, MedX Announces Appointment of Stephen Lockyer as CEO

MedX Health Corp. (“MedX” or the “Company”) (TSXV: MDX), a global leader in teledermatology, is pleased to announce that Stephen Lockyer has been appointed as Chief Executive Officer, effective immediately, in place of Naman Damaghlatrous, who has resigned both as an officer and director of the Company.